Nyxoah (NYXH) Cash from Investing Activities (2025 - 2026)

Nyxoah's quarterly Cash from Investing Activities came in at $5.4 million in Q1 2026, down 36.97% year-on-year from $8.6 million in Q1 2025, and down 36.97% quarter-over-quarter from $8.6 million in Q1 2025.

Nyxoah has reported Cash from Investing Activities for 2 years, with the latest figure at $5.4 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -914.50 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -139.00 Mn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn -58.03 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn -42.70 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -77.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn -102.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn -131.58 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -133.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -65.10 Mn
10 Nyxoah 1,248.49 1,248.49 4.26 Mn 5.39 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 5.39 Mn
Mar 31, 2026 5.39 Mn
Mar 31, 2025 8.55 Mn
Mar 31, 2025 8.55 Mn